已核实 DOI PubMed 相关产品: 2

Bi/mZVI Combined with Citric Acid and Sodium Citrate to Mineralize Multiple Sulfa Antibiotics: Performance and Mechanism

Journal 2022 · IF 5.222 · 11(1): 51 · 发表于 2022 年 1 月 1 日
作者: Xiaoming Su,Hao Lv,Jianyu Gong,Man Zhou
阅读全文 在 PubMed 查看

摘要

The oxidative mineralization of sulfanilamide drugs (SAs) using micro-size zero-valent iron (mZVI) cooperated with a citric acid buffer solution was evaluated. In this study SM2, SMX, and SD could be removed at 66%, 89%, and 83%, respectively, in a 0.5% Bi/mZVI+CA+NaCA system within 2 h. Based on our analysis, the produced ·OH could be ascribed from the complexation between citrate iron (Fe(II)[Cit]−) and the generated H2O2resulting from the activation of O2on the mZVI surface in the Bi/mZVI+CA+NaCA system, further inducing the mineralization of antibiotics. The related possible degradation pathways were proposed. Two similar degradation pathways of SM2, SMX, and SD in the mixed liquid, including hydroxylation and SO2extrusion, were solved. Meanwhile, there was an additional proposed degradation pathway for SMX to be degraded more effectively, as reflected in the opening of the N-O bond on the benzene ring. Therefore, this work provides an experimental basis and theoretical support for the efficient treatment of antibiotic wastewater in real industry by using an iron-based method.Keywords:sulfanilamide drugs;Bi/mZVI;antibiotic;oxidative degradation

本研究中使用的阿拉丁产品

2 款产品在本文中被引用